Skip to content

Reinforced Versus Conventional Anastomosis in Laparoscopic Low Rectal Cancer Resection: A Comparative Study

Reinforced Versus Conventional Anastomosis in Laparoscopic Low Rectal Cancer Resection: A Comparative Study

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07346534
Enrollment
300
Registered
2026-01-16
Start date
2022-06-01
Completion date
2026-12-30
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Low Rectal Cancer, Rectal Neoplasms

Brief summary

Study Description This prospective, controlled clinical study aims to compare the clinical outcomes of reinforced anastomosis using 8-10 interrupted sutures versus the conventional Dixon procedure in patients undergoing laparoscopic low anterior resection for low rectal cancer. Anastomotic leakage remains one of the most significant postoperative complications following low rectal cancer surgery, particularly in laparoscopic procedures due to limited tactile feedback and maneuverability in the pelvic cavity. Reinforcement of the anastomotic site through additional interrupted suturing may provide better mechanical strength and improved healing, potentially reducing the incidence of anastomotic leakage and related morbidities. In this study, eligible patients will be assigned to receive either a conventional laparoscopic Dixon procedure or the same procedure with added reinforcement of the anastomosis using 8-10 interrupted sutures circumferentially. Perioperative outcomes including the rate of anastomotic leakage, postoperative complications, operation time, length of hospital stay, return of bowel function, and quality of life will be assessed and compared between the two groups. The study seeks to provide evidence for optimizing surgical techniques in low rectal cancer treatment and improving patient prognosis.

Interventions

PROCEDUREReinforced Anastomotic Suturing (8-10 Interrupted Sutures)

After completing the laparoscopic low anterior resection (Dixon procedure) for low rectal cancer, the surgeon performs additional reinforcement of the colorectal anastomosis. This is done by placing 8 to 10 interrupted seromuscular sutures circumferentially around the anastomotic site. The goal of this reinforcement is to enhance anastomotic stability, promote healing, and reduce the risk of anastomotic leakage.

PROCEDUREConventional Laparoscopic Dixon Procedure

Patients undergo standard laparoscopic low anterior resection (Dixon procedure) for low rectal cancer. The colorectal anastomosis is performed using a circular stapler without any additional suturing or reinforcement. This represents the conventional surgical approach widely used in clinical practice.

Sponsors

Shanghai 10th People's Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Age between 18 and 85 years. 2. Diagnosed with low rectal adenocarcinoma located within 7 cm from the anal verge by colonoscopy and biopsy. 3. Scheduled for elective laparoscopic low anterior resection (Dixon procedure). 4. Clinical stage I-III (based on preoperative imaging, e.g., MRI/CT) without distant metastasis. 5. Adequate organ function (hematologic, hepatic, renal) to tolerate surgery. 6. Provided written informed consent and willing to comply with study procedures and follow-up.

Exclusion criteria

1. Presence of synchronous distant metastases or other malignancies. 2. History of prior pelvic radiotherapy or major pelvic surgery. 3. Severe uncontrolled comorbidities (e.g., severe cardiovascular, respiratory, hepatic or renal insufficiency). 4. Emergency surgery indication (e.g., bowel obstruction, perforation). 5. Pregnancy or breastfeeding. 6. Known allergy or contraindication to anesthesia or surgical materials used. 7. Participation in another interventional clinical trial within the last 3 months.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Anastomotic LeakageWithin 30 days postoperativelyDefined as clinically significant leakage confirmed by radiological or surgical evidence, classified according to International Study Group of Rectal Cancer (ISREC) criteria.

Secondary

MeasureTime frameDescription
Postoperative Complication RateUp to 30 days after surgeryIncidence of Clavien-Dindo grade II or higher complications.
Operation TimeDuring the surgical procedureTotal duration of surgery from skin incision to skin closure.
Length of Postoperative Hospital StayFrom date of surgery through date of discharge, up to 30 daysNumber of days from surgery to hospital discharge.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026